Royal Bank of Canada’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,190,000
Closed -$6.49M 7410
2023
Q3
$6.49M Buy
+1,190,000
New +$9.53M ﹤0.01% 1899
2023
Q2
Sell
-100,000
Closed -$822K 7504
2023
Q1
$822K Buy
+100,000
New +$1.1M ﹤0.01% 3493
2022
Q4
Sell
-750,000
Closed -$8.89M 7534
2022
Q3
$8.89M Hold
750,000
﹤0.01% 1626
2022
Q2
$11.5M Buy
+750,000
New +$13.5M ﹤0.01% 1467
2020
Q4
Sell
-569,900
Closed -$10M 7205
2020
Q3
$10M Buy
+569,900
New +$10.6M ﹤0.01% 1542
2019
Q4
Sell
-100
Closed -$2K 7002
2019
Q3
$2K Buy
+100
New +$1.84K ﹤0.01% 6293
2019
Q2
Sell
-600
Closed -$11K 7056
2019
Q1
$11K Buy
+600
New +$10.7K ﹤0.01% 5935

Other funds holding MPT

Royal Bank of Canada's MPT Position: Q1 2026 in Review

Royal Bank of Canada increased its Medical Properties Trust (MPT) stake by 11% in Q1 2026, buying an estimated $73.2K and bringing the position to 142,647 shares worth $660K. The position accounts for ﹤0.01% of the portfolio, ranked #3917.

Royal Bank of Canada first reported a position in MPT in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.5M in Q1 2022. 491 funds tracked by Wall St. Rank hold MPT as of Q1 2026.

  • Royal Bank of Canada held 142,647 shares of Medical Properties Trust worth $660K as of Q1 2026.
  • Royal Bank of Canada bought 14,030 Medical Properties Trust shares in Q1 2026, an estimated $73.2K.
  • Medical Properties Trust made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3917 holding.
  • Royal Bank of Canada first reported a position in Medical Properties Trust in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Medical Properties Trust position peaked at $30.5M in Q1 2022.
  • 491 funds tracked by Wall St. Rank held Medical Properties Trust as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.